Skip to content

Journal · Medical mycology · Updated 21 November 2026

Mycopathologia

Read Mycopathologia articles on DeepDyve. No university library needed.

Mycopathologia covers fungi that cause disease, from invasive aspergillosis in patients with blood cancers and Candida auris in wetland waters to skin infections, chromoblastomycosis and genetic risk for fungal infection. Springer Nature publishes it. It was previously published as Mycopathologia et Mycologia Applicata. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.

Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.

Personal plans aren’t for business use. Reading for work? See Enterprise.

Cover of Mycopathologia
Journal cover

Mycopathologia at a glance

Full title
Mycopathologia
Former title
Mycopathologia et Mycologia Applicata
Abbreviation (NLM)
Mycopathologia
Publisher
Springer Nature
Print ISSN
0301-486X
Online ISSN (eISSN)
1573-0832
Current title since
1975
Subjects
Microbiology
Access model
Hybrid (43% free to read in 2026)

Ways to access Mycopathologia

43% of the articles Mycopathologia published from January 1 to November 19, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.

  1. Open access articles. 43% of Mycopathologia articles published from January 1 to November 19, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
  2. The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
  3. Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
  4. NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
  5. A library. Your university, hospital or public library may subscribe to Mycopathologia. Check its journal list and whether it offers remote access.
  6. DeepDyve. Read Mycopathologia articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.

Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.

Impact factor and metrics

Mycopathologia’s 2025 Journal Impact Factor is 4.1, and its 5-year Impact Factor is 3.9.

4.1

Journal Impact Factor (2025)

3.9

5-year Impact Factor (2025)

14 days

Median time to first decision

Source: journal metrics on the Mycopathologia homepage (Springer Nature), checked November 21, 2026. Impact Factor from Clarivate Journal Citation Reports.

Recent Mycopathologia research worth reading

Published February to July 2026. Summaries describe what the authors report.

  1. Open accessInvasive aspergillosis · Hematology

    Clinical Characteristics and Outcomes of Invasive Aspergillosis in Patients with Hematological Malignancies and Transplantation and Cellular Therapies in the Contemporary Era

    In a single-center study of 62 patients with blood cancers or transplants and invasive aspergillosis, the authors report all-cause mortality of 22% at 30 days and 46% at 90 days, with therapeutic antifungal levels linked to lower mortality.

    Lopez et al. · Mycopathologia, published online February 5, 2026 · DOI 10.1007/s11046-025-01046-1

  2. LitStreamCandida auris · One Health

    Environmental Detection of Candidozyma (Candida) auris in Surface Waters of the Gediz Delta, a Critical Coastal Wetland in Türkiye: Expanding One Health Surveillance Perspective

    Testing 80 surface-water samples from five Turkish wetlands, the authors report Candida auris DNA in one sample (1.25%) from the Gediz Delta, confirmed by sequencing, but no viable C. auris in culture, suggesting the DNA persists as residual material.

    Ergen et al. · Mycopathologia, published online July 18, 2026 · DOI 10.1007/s11046-026-01091-4

  3. LitStreamDermatophytes · Fungal taxonomy

    A Study on the Species Diversity, Mating Types, and Clinical Relevance of Trichophyton mentagrophytes/interdigitale Complex Infections in Guizhou Province

    Studying 62 clinical isolates of the Trichophyton mentagrophytes complex from Guizhou, the authors report two groups differing in molecular, phenotypic, mating type and drug susceptibility traits, with hybrid and intermediate strains blurring the line between T. interdigitale and T. mentagrophytes.

    Hu et al. · Mycopathologia, published online May 11, 2026 · DOI 10.1007/s11046-026-01079-0

  4. LitStreamChromoblastomycosis · Tropical disease

    Predominance of Fonsecaea nubica in Chromoblastomycosis: A Single-Centre Study from Southern India

    In 16 confirmed or probable chromoblastomycosis cases in Kerala, India, the authors report that all six cultured Fonsecaea isolates were F. nubica, most patients were male agricultural workers, and 14 of 16 (87.5%) were cured with itraconazole.

    Nair et al. · Mycopathologia, published online June 5, 2026 · DOI 10.1007/s11046-026-01083-4

  5. LitStreamImmunodeficiency · Fungal infections

    CARD9 Mutations in Patients with Fungal Infections: A Comprehensive Literature Review

    Reviewing published cases of 102 CARD9-deficient patients with fungal infections, the authors report candidiasis (34.3%), dermatophytosis (27.5%) and phaeohyphomycosis (23.5%) as the main infections, 43 distinct CARD9 alterations, and clear geographic variation in mutations.

    Shi et al. · Mycopathologia, published online February 13, 2026 · DOI 10.1007/s11046-026-01056-7

See every Mycopathologia article on DeepDyve

Questions about Mycopathologia

How can I read Mycopathologia articles without a subscription?

43% of Mycopathologia articles published from January 1 to November 19, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Mycopathologia articles online for $59 a month or $499 a year after a free first month.

What is the abbreviation for Mycopathologia?

Mycopathologia isn’t abbreviated: its NLM (PubMed) abbreviation is simply Mycopathologia.

What is the ISSN of Mycopathologia?

The print ISSN is 0301-486X and the online ISSN is 1573-0832.

What is the impact factor of Mycopathologia?

Mycopathologia’s Journal Impact Factor is 4.1 (2025), and its 5-year Impact Factor is 3.9, according to Springer Nature’s published metrics.

Is Mycopathologia open access?

Mycopathologia is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 19, 2026, 34 of 79 Mycopathologia articles (43%) carry a Creative Commons license, per Crossref.

Mycopathologia articles on DeepDyve are licensed from Springer Nature. Journal facts as of 21 November 2026.

Start reading Mycopathologia today

One month free, then less than $2 a day. Mycopathologia, plus millions of articles from thousands of journals.

Start free month

Like this: